8-K: Aditxt Faces Nasdaq Delisting Over Bid Price Rule

Aditxt, Inc. has received a delisting notice from Nasdaq due to failure to maintain the minimum $1.00 bid price requirement.

Summary

• Aditxt received a Staff Determination letter from Nasdaq on May 6, 2026, regarding non-compliance with the minimum bid price rule.
• The company's common stock closed below $1.00 for 30 consecutive business days from March 24, 2026, to May 5, 2026.
• Nasdaq denied the standard 180-day compliance period due to the company's history of reverse stock splits exceeding a 250-to-1 cumulative ratio over the past two years.
• The company intends to appeal the decision by requesting a hearing before a Nasdaq Hearings Panel, which will stay delisting actions during the process.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, as the loss of a major exchange listing significantly impairs capital access and investor confidence.

Positives

• The company is actively pursuing an appeal to maintain its Nasdaq listing status.
• The hearing request provides a temporary stay of delisting actions, allowing for continued trading during the appeal process.

Negatives

• The company is currently in violation of Nasdaq Listing Rule 5550(a)(2).
• Nasdaq has explicitly denied the standard 180-day grace period to regain compliance.
• The company's history of significant reverse stock splits has triggered an accelerated delisting process.

Risks

• High risk of delisting from The Nasdaq Capital Market if the appeal is unsuccessful.
• Potential loss of liquidity and institutional investor interest associated with a move to over-the-counter (OTC) markets.
• Uncertainty regarding the company's ability to present a viable plan to regain and maintain compliance to the Nasdaq Hearings Panel.

Future Outlook

The company plans to request a hearing before a Nasdaq Hearings Panel to present a plan to regain compliance, though there is no assurance of success.

Management Comments

• The company intends to timely request a hearing before a Nasdaq Hearings Panel to appeal Nasdaq Staff's determination.

Industry Context

StockSavvy.ai notes that this development reflects a growing trend of micro-cap biotech and technology firms struggling with sustained low share prices and the subsequent regulatory scrutiny regarding listing standards.

Comparison to Industry Standards

• The denial of the 180-day grace period is a strict enforcement action typically reserved for companies with repeated non-compliance or aggressive capital structure adjustments.
• Many peers in the small-cap sector face similar challenges, but the cumulative 250-to-1 reverse split ratio puts Aditxt in a more precarious regulatory position than standard non-compliance cases.

Legal Proceedings

• The company is currently engaged in an administrative process with Nasdaq regarding its listing status.

Stakeholder Impact

• Shareholders face increased volatility and potential loss of liquidity if the stock is delisted.
• The company's ability to raise future capital may be severely constrained by the loss of Nasdaq listing.

Next Steps

• Submit a formal request for a hearing before the Nasdaq Hearings Panel.
• Prepare and present a compliance plan to the Panel to justify continued listing.

Key Dates

Recommendation

The threat of delisting combined with a history of extreme reverse stock splits suggests fundamental instability, making the stock a high-risk asset that institutional investors would likely avoid.

Keywords

Aditxt, ADTX, Nasdaq, delisting, bid price, reverse stock split, compliance